KLP Kapitalforvaltning’s Definium Therapeutics DFTX Stock Holding History

KLP Kapitalforvaltning’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Buy	25,000 +8,000	+47%	+$198K	﹤0.01%	1036
2026 Q1	$321K	Hold	17,000	–	–	﹤0.01%	1630
2025 Q4	$228K	Buy	17,000 +6,600	+63%	+$81.7K	﹤0.01%	1791
2025 Q3	$123K	Hold	10,400	–	–	﹤0.01%	2011
2025 Q2	$67.5K	Hold	10,400	–	–	﹤0.01%	2120
2025 Q1	$60.8K	Hold	10,400	–	–	﹤0.01%	2166
2024 Q4	$72.4K	Buy	+10,400	New	+$71.6K	﹤0.01%	2184

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

KLP Kapitalforvaltning's DFTX Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Definium Therapeutics (DFTX) stake by 47% in Q2 2026, buying an estimated $198K and bringing the position to 25,000 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

KLP Kapitalforvaltning first reported a position in DFTX in Q4 2024 and has held it in 7 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

KLP Kapitalforvaltning held 25,000 shares of Definium Therapeutics worth $1.18M as of Q2 2026.
KLP Kapitalforvaltning bought 8,000 Definium Therapeutics shares in Q2 2026, an estimated $198K.
Definium Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1036 holding.
KLP Kapitalforvaltning first reported a position in Definium Therapeutics in Q4 2024 and has held it in 7 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.